Los Angeles, CA -- (SBWire) -- 02/17/2019 --A market research report is a perfect tool for digging deep into critical aspects of the global Pimozide market and closely understanding factors that influence its growth. Our research analysts are experienced enough to provide you with the right information about the global Pimozide market to help your business propel forward in the coming years. What makes us different from other market researchers is our high level of analysis that helps you to identify key opportunities available in the global Pimozide market. The report provides every bit of information about the global Pimozide market related to major market segments, vendor landscape, geographical growth, and other significant factors.
The global Pimozide market is valued at 12 million US$ in 2018 is expected to reach 11 million US$ by the end of 2025, growing at a CAGR of -0.9% during 2019-2025.
We deliver market intelligence according to your requirements. This report can be customized as per your business needs. We meet client expectations with the help of our peerless pre-execution, execution, and post-execution engagement models. Our analysts offer quantified B2B research on market threats and opportunities. They also provide qualitative analysis of the global Pimozide market.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/965623/global-pimozide-depth-research-report
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis, it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Pimozide includes 1Mg, 2Mg, 4Mg, and the proportion of 2Mg in 2017 is about 53%.
Pimozide is widely used in hospitals, drugstores and other places. The most proportion of Pimozide is used for hospitals in 2017 is 54%.
This report focuses on Pimozide volume and value at the global level, regional level and company level. From a global perspective, this report represents an overall Pimozide market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At the company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
Major Key Manufacturers of Pimozide Market are:
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Pimozide market includes market size, segmentation data and geographical analysis of market growth trends, leading companies, and microeconomic information.
Major Classification as follows:
1Mg
2Mg
4Mg
Major Application as follows:
Hospitals
Drugstores
Others
Get Complete Report in your Inbox within 24 hours: https://www.qyresearch.com/settlement/pre/8e0ccc2938f155df4042a5bb9569c4b6,0,1,Global%20Pimozide%20Depth%20Research%20Report%202019
Regions Covered in the Global Pimozide Market:
The Middle East and Africa (GCC Countries and Egypt)
North America (the United States, Mexico, and Canada)
South America (Brazil etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
Few of the questions answered through the report
(1) How will the global Pimozide market performance during the forecast period? What will be the market size in terms of value and volume?
(2) Which segment will drive the global Pimozide market? Which regional market will show extensive growth in the future? What are the reasons?
(3) How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
(4) What are the key strategies adopted by players to sustain themselves in the global Pimozide market?
(5) How will these strategies influence market growth and competition?
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.
Pimozide Market Will Surge at 0.9% CAGR Up to 2025: QY Research, Inc.